Skip to main content
EH

Essential HCP

This startup provides a platform for gathering and analyzing data related to healthcare professionals (HCPs). It delivers insights and intelligence about HCPs at scale, potentially for use in marketing, sales, or research within the healthcare industry.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Life science companies often struggle to understand the real-time opinions and attitudes of healthcare professionals (HCPs) regarding therapies, clinical trial results, and emerging trends. Traditional market research methods can be slow, expensive, and may not capture the nuances of rapidly evolving online conversations. This lack of timely and comprehensive insights hinders informed decision-making in medical affairs and marketing.

Solution

Essential HCP provides life science companies with AI-powered social listening and insights reports derived from online conversations among HCPs, patients, caregivers, and key opinion leaders. The platform aggregates and analyzes data from various open-access platforms, including Twitter(X), Reddit, Bluesky, Substack, podcasts, and online forums, to deliver unbiased intelligence at scale. Essential HCP offers custom research and insights reports that blend qualitative richness with quantitative context, providing a deeper understanding of HCP perspectives, patient experiences, and market dynamics. These insights enable faster, cost-effective decision-making throughout the product lifecycle, from pre-launch preparation to launch tracking and digital opinion leader analysis.

Target Audience

The primary target audience includes pharmaceutical companies, pre-clinical biotechnology companies, market research firms, and digital/advertising agencies serving healthcare clients.

Features

  • AI-powered social listening to capture real-time conversations among HCPs, patients, and caregivers.
  • Custom research and insights reports tailored to specific brand objectives and therapeutic areas.
  • Analysis of HCP opinions on therapies, clinical trial results, FDA approvals, and emerging trends.
  • Identification of key opinion leaders (KOLs) and rising stars within the digital landscape.
  • Monitoring of audio platforms, including podcasts and FDA ODAC meetings, for key opinions.
  • Analysis of patient and caregiver perceptions of drug pricing, access issues, and alternative treatment options.
  • Graph-based algorithms to map networks and clusters of HCPs based on online interactions.
This profile is AI-generated and may contain inaccuracies.